4.5 Article

A randomised controlled trial into the effects of food on ADHD

Journal

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
Volume 18, Issue 1, Pages 12-19

Publisher

SPRINGER
DOI: 10.1007/s00787-008-0695-7

Keywords

ADHD; few foods diet; elimination diet; children; randomised controlled trial

Funding

  1. Foundation for Children's Welfare Stamps Netherlands
  2. Foundation Nuts Ohra
  3. Matty Brand Foundation
  4. Foundation of Child and Behaviour

Ask authors/readers for more resources

The aim of this study is to assess the efficacy of a restricted elimination diet in reducing symptoms in an unselected group of children with Attention deficit/hyperactivity disorder (ADHD). Dietary studies have already shown evidence of efficacy in selected subgroups. Twenty-seven children (mean age 6.2) who all met the DSM-IV criteria for ADHD, were assigned randomly to either an intervention group (15/27) or a waiting-list control group (12/27). Primary endpoint was the clinical response, i.e. a decrease in the symptom scores by 50% or more, at week 9 based on parent and teacher ratings on the abbreviated ten-item Conners Scale and the ADHD-DSM-IV Rating Scale. The intention-to-treat analysis showed that the number of clinical responders in the intervention group was significantly larger than that in the control group [parent ratings 11/15 (73%) versus 0/12 (0%); teacher ratings, 7/10 (70%) versus 0/7 (0%)]. The Number of ADHD criteria on the ADHD Rating Scale showed an effect size of 2.1 (cohen's d) and a scale reduction of 69.4%. Comorbid symptoms of oppositional defiant disorder also showed a significantly greater decrease in the intervention group than it did in the control group (cohens's d 1.1, scale reduction 45.3%). A strictly supervised elimination diet may be a valuable instrument in testing young children with ADHD on whether dietary factors may contribute to the manifestation of the disorder and may have a beneficial effect on the children's behaviour.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Psychology, Clinical

Alexithymia in autism: cross-sectional and longitudinal associations with social-communication difficulties, anxiety and depression symptoms

Bethany F. M. Oakley, Emily J. H. Jones, Daisy Crawley, Tony Charman, Jan Buitelaar, Julian Tillmann, Declan G. Murphy, Eva Loth

Summary: The study found that autistic individuals have significantly higher levels of alexithymia, with difficulties in identifying and describing emotions playing a role in social-communication difficulties and anxiety severity. Difficulty in describing feelings is associated with social-communication difficulties, while difficulty in identifying feelings is associated with anxiety severity, impacting long-term clinical outcomes for individuals with autism.

PSYCHOLOGICAL MEDICINE (2022)

Review Psychology, Developmental

The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG)

David Coghill, Tobias Banaschewski, Samuele Cortese, Philip Asherson, Daniel Brandeis, Jan Buitelaar, David Daley, Marina Danckaerts, Ralf W. Dittmann, Manfred Doepfner, Maite Ferrin, Chris Hollis, Martin Holtmann, Santosh Paramala, Edmund Sonuga-Barke, Cesar Soutullo, Hans-Christoph Steinhausen, Saskia van der Oord, Ian C. K. Wong, Alessandro Zuddas, Emily Simonoff

Summary: ADHD is a common neurodevelopmental disorder in children and adolescents, and timely interventions are a priority. However, current research reports and reviews on interventions for ADHD often lack consistency and are difficult to interpret. Clinicians need to consider methodological issues and gaps in the evidence when evaluating treatments for ADHD.

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2023)

Article Psychology, Developmental

Internalizing problems before and during the COVID-19 pandemic in independent samples of Dutch children and adolescents with and without pre-existing mental health problems

Karen Fischer, Jacintha M. Tieskens, Michiel A. J. Luijten, Josjan Zijlmans, Hedy A. van Oers, Rowdy de Groot, Daniel van der Doelen, Hanneke van Ewijk, Helen Klip, Rikkert M. van der Lans, Ronald De Meyer, Malindi van der Mheen, Maud M. van Muilekom, I. Hyun Ruisch, Lorynn Teela, Germie van den Berg, Hilgo Bruining, Rachel van der Rijken, Jan Buitelaar, Pieter J. Hoekstra, Ramon Lindauer, Kim J. Oostrom, Wouter Staal, Robert Vermeiren, Ronald Cornet, Lotte Haverman, Meike Bartels, Tinca J. C. Polderman, Arne Popma

Summary: The study aimed to assess internalizing problems before and during the COVID-19 pandemic. The results showed that internalizing problems were higher during the first peak of the pandemic in the general population, but similar or lower levels were observed over the course of the pandemic. Children in the clinical population reported more internalizing symptoms during the pandemic, while parents did not report differences. These findings indicate negative effects of the pandemic on children and adolescents' internalizing problems in both general and clinical populations.

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2023)

Review Psychology, Developmental

A meta-analytic review of the impact of ADHD medications on anxiety and depression in children and adolescents

Annie Bryant, Hope Schlesinger, Athina Sideri, Joni Holmes, Jan Buitelaar, Richard Meiser-Stedman

Summary: This meta-analytic review examined the effects of medications on anxiety and depression symptoms in children and adolescents with ADHD. The study found no significant improvement in symptoms of anxiety or depression with ADHD medication compared to placebo control. The lack of reporting on mental health outcomes in ADHD drug trials for children and adolescents was highlighted, emphasizing the importance of standardized measurement in future trials.

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2023)

Article Psychology, Clinical

Age-related brain deviations and aggression

Nathalie E. Holz, Dorothea L. Floris, Alberto Llera, Pascal M. Aggensteiner, Seyed Mostafa Kia, Thomas Wolfers, Sarah Baumeister, Boris Boettinger, Jeffrey C. Glennon, Pieter J. Hoekstra, Andrea Dietrich, Melanie C. Saam, Ulrike M. E. Schulze, David J. Lythgoe, Steve C. R. Williams, Paramala Santosh, Mireia Rosa-Justicia, Nuria Bargallo, Josefina Castro-Fornieles, Celso Arango, Maria J. Penzol, Susanne Walitza, Andreas Meyer-Lindenberg, Marcel Zwiers, Barbara Franke, Jan Buitelaar, Jilly Naaijen, Daniel Brandeis, Christian Beckmann, Tobias Banaschewski, Andre F. Marquand

Summary: This study aimed to reveal the neurobiological characteristics of disruptive behavior disorders (DBD) by integrating individual deviation patterns from multiple imaging modalities. The results showed that DBD patients exhibited increased age-related deviations in the amygdala, suggesting a possible maturational delay. Furthermore, the study identified neural signatures associated with aggression, including the default mode network (DMN), striatum, and amygdala.

PSYCHOLOGICAL MEDICINE (2023)

Article Multidisciplinary Sciences

Local molecular and global connectomic contributions to cross-disorder cortical abnormalities

Justine Y. Hansen, Golia Shafiei, Jacob W. Vogel, Kelly Smart, Carrie E. Bearden, Martine Hoogman, Barbara Franke, Daan van Rooij, Jan Buitelaar, Carrie R. McDonald, Sanjay M. Sisodiya, Lianne Schmaal, Dick J. Veltman, Odile A. van den Heuvel, Dan J. Stein, Theo G. M. van Erp, Christopher R. K. Ching, Ole A. Andreassen, Tomas Hajek, Nils Opel, Gemma Modinos, Andre Aleman, Ysbrand van der Werf, Neda Jahanshad, Sophia Thomopoulos, Paul M. Thompson, Richard E. Carson, Alain Dagher, Bratislav Misic

Summary: Changes in structural and functional connectivity can lead to neurodegeneration and neurodevelopmental diseases. In this study, the authors investigate the molecular and connectomic patterns in various neurological, psychiatric, and neurodevelopmental diseases from the ENIGMA consortium. They find a relationship between molecular vulnerability, white-matter architecture, and cortical disorder profiles. Local attributes, especially neurotransmitter receptor profiles, are the best predictors of disorder-specific cortical morphology and cross-disorder similarity. Furthermore, they identify specific network epicenters involved in cross-disorder abnormalities. Overall, this study highlights the importance of local molecular attributes and global connectivity in shaping cortical abnormalities across different brain disorders.

NATURE COMMUNICATIONS (2022)

Review Behavioral Sciences

Toward Precision Medicine in ADHD

Jan Buitelaar, Sven Bolte, Daniel Brandeis, Arthur Caye, Nina Christmann, Samuele Cortese, David Coghill, Stephen V. Faraone, Barbara Franke, Markus Gleitz, Corina U. Greven, Sandra Kooij, Douglas Teixeira Leffa, Nanda Rommelse, Jeffrey H. Newcorn, Guilherme V. Polanczyk, Luis Augusto Rohde, Emily Simonoff, Mark Stein, Benedetto Vitiello, Yanki Yazgan, Michael Roesler, Manfred Doepfner, Tobias Banaschewski

Summary: ADHD is a complex neurodevelopmental condition with no curative treatments available. Pharmacological treatments are generally effective and safe, but there is significant variability among patients in terms of treatment response and tolerability. There is currently a lack of evidence-based decision tools for allocating treatments based on patient characteristics. Further research is needed to identify biomarkers that can predict treatment response.

FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2022)

Meeting Abstract Clinical Neurology

STRUCTURAL MODELS OF GENOME-WIDE COVARIANCE IDENTIFY MULTIPLE GENETIC INFLUENCES ACROSS ASD SYMPTOMS

Lucia de Hoyos, Maria T. Barendse, Fenja Schlag, Marjolein M. J. van Donkelaar, Ellen Verhoef, Chin Yang Shapland, Jan Buitelaar, Brad Verhulst, Simon E. Fisher, Dheeraj Rai, Beate St Pourcain

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2022)

Article Psychiatry

Structural brain morphometry as classifier and predictor of ADHD and reward-related comorbidities

Daan van Rooij, Yanli Zhang-James, Jan Buitelaar, Stephen V. Faraone, Andreas Reif, Oliver Grimm

Summary: Attention deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder that can be associated with other disorders. This study used machine learning algorithms to analyze the brain morphology of individuals with ADHD and comorbid depression, substance use disorder (SUD), and obesity. The results suggest that the current methods cannot differentiate between ADHD with or without comorbidities.

FRONTIERS IN PSYCHIATRY (2022)

Article Psychiatry

Enhancing neuroimaging genetics through meta-analysis for Tourette syndrome (ENIGMA-TS): A worldwide platform for collaboration

Peristera Paschou, Yin Jin, Kirsten Mueller-Vahl, Harald E. Moeller, Renata Rizzo, Pieter J. Hoekstra, Veit Roessner, Nanette Mol Debes, Yulia Worbe, Andreas Hartmann, Pablo Mir, Danielle Cath, Irene Neuner, Heike Eichele, Chencheng Zhang, Katarzyna Lewandowska, Alexander Munchau, Julius Verrel, Richard Musil, Tim J. Silk, Colleen A. Hanlon, Emily D. Bihun, Valerie Brandt, Andrea Dietrich, Natalie Forde, Christos Ganos, Deanna J. Greene, Chunguang Chu, Michel J. Grothe, Tamara Hershey, Piotr Janik, Jonathan M. Koller, Juan Francisco Martin-Rodriguez, Karsten Mueller, Stefano Palmucci, Adriana Prato, Shukti Ramkiran, Federica Saia, Natalia Szejko, Renzo Torrecuso, Zeynep Tumer, Anne Uhlmann, Tanja Veselinovic, Tomasz Wolanczyk, Jade-Jocelyne Zouki, Pritesh Jain, Apostolia Topaloudi, Mary Kaka, Zhiyu Yang, Petros Drineas, Sophia Thomopoulos, Tonya White, Dick J. Veltman, Lianne Schmaal, Dan J. Stein, Jan Buitelaar, Barbara Franke, Odile van den Heuvel, Neda Jahanshad, Paul M. Thompson, Kevin J. Black

Summary: TS is characterized by multiple motor and vocal tics and high comorbidity rates with other neuropsychiatric disorders. The ENIGMA-TS working group aims to understand brain structure and function in TS and related disorders through collaborative efforts and transdiagnostic approaches.

FRONTIERS IN PSYCHIATRY (2022)

Review Psychology, Developmental

Remote assessment of ADHD in children and adolescents: recommendations from the European ADHD Guidelines Group following the clinical experience during the COVID-19 pandemic

P. Santosh, S. Cortese, C. Hollis, S. Bolte, D. Daley, D. Coghill, M. Holtmann, E. J. S. Sonuga-Barke, J. Buitelaar, T. Banaschewski, A. Stringaris, M. Doepfner, S. Van der Oord, S. Carucci, D. Brandeis, P. Nagy, M. Ferrin, D. Baeyens, B. J. van den Hoofdakker, D. Purper-Ouakil, A. Ramos-Quiroga, M. Romanos, C. A. Soutullo, A. Thapar, I. C. K. Wong, A. Zuddas, C. Galera, E. Simonoff

Summary: The COVID-19 pandemic has led to changes in ADHD services, with remote assessments being widely adopted. However, there is a lack of clear guidance on how to conduct these assessments effectively. Therefore, the European ADHD Guidelines Group discusses the strengths and weaknesses of remote assessments and provides recommendations for future studies and clinical practice.

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2023)

Article Clinical Neurology

The impact of the COVID-19 pandemic on ADHD medicine consumption in 47 countries and regions

Sophie Gimbach, Daniel Vogel, Roland Fried, Stephen Faraone, Tobias Banaschewski, Jan Buitelaar, Manfred Doepfner, Richard Ammer

Summary: The study aims to measure the impact of the COVID-19 pandemic on global and national consumption of ADHD medication using pharmaceutical sales data from 2014 to 2021 across 47 countries. A SARIMA model was used to predict medication consumption in 2020 and 2021 based on historical data. The findings show that the pandemic resulted in a significant decrease in ADHD medication consumption in 2020, but an increase in consumption in 2021, with a strong correlation to government anti-pandemic policies.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2023)

Article Psychology, Clinical

Understanding the Nature of Face Processing in Early Autism: A Prospective Study

Charlotte Tye, Giorgia Bussu, Teodora Gliga, Mayada Elsabbagh, Greg Pasco, Kristinn Johnsen, Tony Charman, Emily J. H. Jones, Jan Buitelaar, Mark H. Johnson

Summary: Dimensional approaches to psychopathology help to understand the mechanisms of neurodevelopmental disorders by investigating the core neurocognitive domains interacting at the individual level. Embedding this approach in prospective longitudinal studies can reveal domain-specific alterations and their variations across distinct phenotypic subgroups.

JOURNAL OF PSYCHOPATHOLOGY AND CLINICAL SCIENCE (2022)

Article Linguistics

Neural Tracking in Infancy Predicts Language Development in Children With and Without Family History of Autism

Katharina H. Menn, Emma K. Ward, Ricarda Braukmann, Carlijn van den Boomen, Jan Buitelaar, Sabine Hunnius, Tineke M. Snijders

Summary: This study investigates the relationship between tracking sung nursery rhymes and language development, as well as autism symptoms, in infants with a family history of autism. The results show significant speech-brain coherence in infants at both 10 and 14 months. The tracking ability in the stressed syllable rate predicts later vocabulary, but no evidence for a relationship with autism symptoms was found.

NEUROBIOLOGY OF LANGUAGE (2022)

Meeting Abstract Behavioral Sciences

Structural Models of Genome-Wide Covariance Identify Multiple Genetic Influences Across ASD Symptoms

Lucia de Hoyos, Maria T. Barendse, Fenja Schlag, Marjolein M. J. van Donkelaar, Ellen Verhoef, Chin Yang Shapland, Jan Buitelaar, Brad Verhulst, Simon E. Fischer, Dheeraj Rai, Beate St Pourcain

BEHAVIOR GENETICS (2022)

No Data Available